Prosthetic heart valve thrombosis: Pathogenesis, diagnosis and management

International Journal of Cardiology

Volumn 110, Issue 1, 2006, Pages 1-6

  Cáceres Lóriga, Fidel Manuel ^a   Pérez López, Horacio ^a   Santos Gracia, José ^a   Morlans Hernandez, Karel ^a  

^a Inst Cardiol Cardiovasc Surg   (Cuba)

Author keywords

Prosthetic heart valve thrombosis; Prosthetic valve; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTIFIBRINOLYTIC AGENT; APROTININ; BLOOD CLOTTING FACTOR 7; FIBRINOLYTIC AGENT; HEPARIN; PROTHROMBIN COMPLEX; STREPTOKINASE; TRANEXAMIC ACID; UROKINASE;

ANTICOAGULANT THERAPY; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG HALF LIFE; FIBRINOLYTIC THERAPY; GASTROINTESTINAL HEMORRHAGE; HEART VALVE PROSTHESIS; HUMAN; INTRACARDIAC THROMBOSIS; LUNG HEMORRHAGE; META ANALYSIS; PATHOGENESIS; PRIORITY JOURNAL; RETROPERITONEAL HEMORRHAGE; REVIEW; SYSTEMATIC REVIEW; THROMBECTOMY; THROMBOEMBOLISM;

FIBRINOLYTIC AGENTS; HEART VALVE PROSTHESIS; HUMANS; THROMBOLYTIC THERAPY; THROMBOSIS;

EID: 33747436973     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.06.051     Document Type: Review

References (48)

1. Thorburn C.W., Morgan J.J., Sanan M.X., and Chang V.P. Long-term results of tricuspid valve replacement and the problem of the prosthetic valve thrombosis. Am J Cardiol 51 (1983) 1128-1132
2. Cannegieter S.C., Rosendaal F.R., and Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 89 (1994) 635-641
3. Vongpatanasin W., Hillis D., and Lange R.A. Prosthetic heart valve. N Engl J Med 335 (1996) 407-416
4. Lengyel M. Management of prosthetic valve thrombosis. J Heart Valve Dis 13 (2004) 329-334
5. Horstkotte D., and Burchkhardt D. Prosthetic valve thrombosis. J Heart Valve Dis 4 (1995) 141-153
6. Taljaard J.J., and Doubell A.F. Prosthetic valve obstruction at Tygerberg Hospital between January 1991 and February 2001. Cardiovasc J South Afr 14 (2003) 182-188
7. Piper C, Horstkotte D. State of the Art Anticoagulation Management. J Heart Valve Dis;13 (Suppl. 1):S76-S80.
8. Silber H., Khan S.S., Matloff J.M., Chaux A., DeRobertis M., and Gray R. The St. Jude valve: thrombolysis as the first line of therapy for cardiac valve thrombosis. Circulation 87 (1993) 30-37
9. Reddy N.K., Padmanabhan T.N.C., Singh S., et al. Thrombolysis in left-sided prosthetic valve occlusion: immediate and follow-up results. Ann Thorac Surg 58 (1994) 462-471
10. Witchitz S., Veyrat C., Moison P., Scheiman N., and Rozentajn L. Fibrinolytic treatment in thrombus on prosthetic heart valve. Br Heart J 44 (1980) 545-554
11. Czer L.S., Weiss M., and Bateman T.M. Fibrinolytic therapy of St. Jude valve thrombosis under guidance of digital cinefluoroscopy. J Am Coll Cardiol 5 (1985) 1244-1249
12. Barbetseas J., and Zoghbi W.A. Evaluation of prosthetic valve function and associated complications. Cardiol Clin 16 3 (1998 (Aug)) 505-530
13. Baumgartner H., Khan S., DeRobertis M., Czer L., and Maurer G. Discrepancies between Doppler and catheter gradients in aortic prosthetic valves in vitro: a manifestation of localized gradients and pressure recovery. Circulation 82 (1990) 1467-1475
14. Casssidy J.M., Smith M.D., Gurley J.C., Booth D.C., Cater A.L., and Salley R.K. Detection of thrombosis of St. Jude Medical prostheses by transesophageal echocardiography. Am Heart J 122 (1991) 1466-1469
15. Dzavik V., Cohen G., and Chan K.L. Role of transesophageal echocardiography in the diagnosis and management of prosthetic valve thrombosis. J Am Coll Cardiol 18 (1991) 1829-1833
16. Barbetseas J., Nagueh S.F., Pitsavos C., Toutouzas P.K., Quiñones M.A., and Zoghbi W.A. Differentiating thrombus from pannus formation in obstructed mechanical prosthetic valves: an evaluation of clinical, transthoracic and transesophageal echocardiography parameters. J Am Coll Cardiol 32 (1998) 1410-1417
17. Aoyagy S., Fukunaga S., Suzuki S., Nishi Y., Orjoji A., and Kosuga K. Obstruction of mechanical valve prostheses: clinical diagnosis and surgical or nonsurgical treatment. Surg Today 26 (1996) 400-406
18. Deviri E., Sareli P., and Wisenbaugh T. Obstruction of mechanical heart valve prostheses: clinical aspects and surgical management. J Am Coll Cardiol 17 (1991) 646-650
19. Martinell J., Jiménez A., Rábago G., Artiz V., Fraile J., and Farré J. Mechanical cardiac valve thrombosis: is thrombectomy justified?. Circulation 84 (Suppl) III (1991) 70-75
20. Vitale N., Renzulli A., and Cerasuolo F. Prosthetic valve obstruction: thrombolysis versus operation. Ann Thorac Surg 57 (1994) 365-370
21. Azpitarte J., Sánchez-Ramos J., Urda T., Vivancos R., Oyonarte J.M., and Malpartida F. Trombosis valvular protésica: ¿cuál es la terapia inicial más apropiada?. Rev Esp Cardiol 54 (2001) 1367-1376
22. Lengyel M., Fuster V., Keltai M., et al. Guidelines for management of left-side prosthetic valve thrombosis: a role for thrombolytic therapy. Consensus Conference on prosthetic valve thrombosis. J Am Coll Cardiol 30 (1997) 1521-1526
23. Roudaut R., Labbe T., Lorient-Roudaut M., et al. Mechanical cardiac thrombosis: is fibrinolysis justified?. Circulation 86 Suppl II (1992) II-8-II-15
24. Solorio S., Sánchez H., Madrid R., et al. Trombolisis en la trombosis protésicas valvular mecánica. Manejo con Estreptocinasa. Arch Inst Cardiol Méx 64 (1994) 51-55
25. Gupta D., Kothari S.S., Bahl V.K., et al. Thrombolytic therapy for prosthetic valve thrombosis: short- and long-term results. Am Heart J 140 (2000) 906-916
26. Villanyi J., Wladika Z.S., and Bartel I. Diagnosis and treatment of tricuspid mechanical prosthetic valve dysfunction. Eur Heart J 13 (1992) 374-381 [Suppl]
27. Birdi I., Angelini G.D., and Bryan A.J. Thrombolytic therapy for left-sided heart valve thrombosis. J Heart Valve Dis 4 (1995) 154-159
28. Graver L.M., Gelber P.M., and Tyras. The risks and benefits of thrombolytic therapy in acute aortic and mitral prosthetic valve dysfunction: report of a case and review of the literature. Ann Thorac Surg 46 (1988) 85-88
29. Özkan M., Kaymaz C., Kirma C., et al. Intravenous thrombolytic treatment of mechanical prosthetic valve thrombosis: a study using transesophageal echocardiography. J Am Coll Cardiol 35 (2000) 1881-1889
30. Shapira Y., Herz I., Vaturi M., et al. Thrombolysis is an effective and safe therapy in stuck bileaflet mitral valves in the absence of high risk thrombi. J Am Coll Cardiol 35 (2000) 1874-1880
31. Lengyel M., Vegh G., and Vandor L. Thrombolysis is superior to heparin for non-obstructive mitral mechanical valve thrombosis. J Heart Valve Dis 8 (1999) 167-173
32. Lengyel M., and Vandor L. The role of thrombolysis in the management of left-sided prosthetic valve thrombosis: a study of 85 cases diagnosed by transesophageal echocardiography. J Heart Valve Dis 10 (2001) 636-649
33. López H., Cáceres F.M., Morlans K., et al. Thrombolytic therapy with recombinant streptokinase for prosthetic valve thrombosis. J Card Surg 17 (2002) 387-393
34. Azzano O., French P., Robin J., et al. Traitement thrombolytique par rt-PA d'une thrombose de prothese valvulaire tricuspidienne chez une femme enceinte. Arch Mal Coeur 88 (1995) 267-270
35. Sbarouni E., and Oakley C.M. Outcome of pregnancy in women with valve prostheses. Br Heart J 71 (1994) 196-201
36. Tong A.T., Roudaut R., Ozkan M., et al. Transesophageal echocardiography improves risk assessment of thrombolysis of prosthetic valve thrombosis: results of the International PRO-TEE Registry. J Am Coll Cardiol 43 (2004) 77-84
37. Hanania G., Thomas D., Michel P.L., et al. Grosseses chez les porteuses de protheses valvulaires. Étude coopérative rétrospective francaise (155 cas.). Arch Mal Coeur 87 (1994) 429-437
38. Young E., Shapiro S.M., French W., and Grinzton L.E. Use of transesophageal echocardiography during thrombolysis with plasminogen activator of a thrombosed prosthetic mitral valve. J Am Soc Echocardiogr 5 (1992) 153-158
39. Ramamurthy S., Talwar K.K., Saxena A., Juneja R., and Takkar D. Prosthetic mitral valve thrombosis in pregnancy successfully treated with streptokinase. Am Heart J 127 (1994) 446-448
40. Feyfel M., Bourzoufi K., Huin G., Subtil D., and Puech F. Recombinant tissue type plasminogen activator treatment of thrombosed mitral valve prosthesis during pregnancy. Can J Anaesth 44 (1997) 735-738
41. Rinaldi J.P., Yassine M., Aboujaoudé F., et al. Thrombolyse réussie d'une thrombose de prothése aortique par activateur tissulaire du plasminogéne durant la grossese. Arch Mal Coeur 92 (1999) 427-430
42. Sánchez A., Cortadellas J., Figueras, González T., and Soler J. Tratamiento fibrinolítico en pacientes con trombosis protésica y elevado riesgo quirúrgico. Rev Esp Cardiol 54 (2001) 1452-1455
43. Guerrero F., Vázquez G., and Reina A. Thrombolytic treatment for massive thrombosis of prosthetic cardiac valves. Intensive Care Med 19 (1993) 145-150
44. Wardlaw J.M., Zoppo G., Yamaguchi T., and Berge E. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 3 (2003) [CD000213]
45. Koca V., Bozat T., Saricamis C., Akkaya V., Yavuz S., and Özdemir A. The use of transoesophageal echocardiography guidance of thrombolytic therapy in prosthetic mitral valve thrombosis. J Heart Valve Dis 9 (2000) 374-378
46. Mayer S.A., Brun N.C., Begtrup K., et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 352 (2005) 777-785
47. Lengyel M. Thrombolysis should be regarded as first-line therapy for prosthetic valve thrombosis in the absence of contraindications. J Am Coll Cardiol 45 (2005) 325
48. Alpert J.S. The thrombosed prosthetic valve. J Am Coll Cardiol 41 (2003) 659-660